Core G - The Clinical Investigation and Biostatistics (CB) Core supports and enables studies of the pathogenesis, treatment, and prevention of HIV disease and its complications. The Core functions as a central access point for basic, clinical, and translational investigators by providing expertise in clinical study design, study implementation, patient recruitment, clinical evaluations for research, and specimen and data collection. Importantly, the Core provides biostatistical consultation for study design, grant preparation, power considerations and statistical analysis of study results as well as assistance with manuscript preparation. The CFAR web portal allows users to submit requests to the CB Core in a uniform, easy-to-use, and readily available format that ensures rapid response to requested services. A key innovation of the CB Core is the availability of prospectively collected, high quality, real-time clinical data, from the 3000 patients in current clinical care at the Owen Clinic, which is linked to a specimen repository and patient-based outcome measures (i.e., quality of life, adherence). The data and specimens allow for identification of and access to subjects and specimens that meet specific criteria for interventional, epidemiologic, behavioral, or basic science projects. The Core interacts with other CFAR cores to enable research requiring laboratory and clinical expertise, fosters multidisciplinary research among basic, clinical, and behavioral scientists, and teaches and mentors junior investigators in the principles of clinical investigation. CFAR funding permits the CB Core to offer its services to new and junior investigators without charge in most cases. Quality-assured data sets, with key data elements that have been reviewed for consistent definitions and accuracy, are provided free to the CFAR academic community. The resources from the CB Core have been further expanded and leveraged by collaboration with seven additional CFARs across the country to form the CFAR Network of Integrated Clinical Systems (CNICS).
The specific aims of the CB Core are: to support clinical investigation and translational research;to encourage, mentor and train the next generation of HIV clinical investigators;and to provide education about and access to HIV-related research opportunities and CFAR research findings to all HIV-infected individuals, including women and underrepresented minorities in the CFAR community.

Public Health Relevance

The Clinical Investigation and Biostatistics (CB) Core promotes and enables research aimed at important questions concerning the pathogenesis, treatment, and prevention of HIV disease and its complications. The Core functions as a central access point for basic, clinical and translational investigators by providing key resources including expertise in study design and implementation, statistical analysis, patient recruitment, research clinical evaluation and specimen and data collection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-20
Application #
8648959
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
20
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Rhodes, Tim (2018) The becoming of methadone in Kenya: How an intervention's implementation constitutes recovery potential. Soc Sci Med 201:71-79
Morales, Mario; Rafful, Claudia; Gaines, Tommi L et al. (2018) Factors associated with extrajudicial arrest for syringe possession: results of a department-wide survey of municipal police in Tijuana, Mexico. BMC Int Health Hum Rights 18:36
Ben Hamida, Amen; Rafful, Claudia; Jain, Sonia et al. (2018) Non-injection Drug Use and Injection Initiation Assistance among People Who Inject Drugs in Tijuana, Mexico. J Urban Health 95:83-90
Christensen-Quick, Aaron; Chaillon, Antoine; Yek, Christina et al. (2018) Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy. J Acquir Immune Defic Syndr 79:e104-e107
Groessl, Erik J; Ganiats, Theodore G; Hillery, Naomi et al. (2018) Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis 18:102
Dillon, Stephanie M; Guo, Kejun; Austin, Gregory L et al. (2018) A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis. AIDS 32:1599-1611
Goldenberg, Shira M; Rocha Jiménez, Teresita; Brouwer, Kimberly C et al. (2018) Influence of indoor work environments on health, safety, and human rights among migrant sex workers at the Guatemala-Mexico Border: a call for occupational health and safety interventions. BMC Int Health Hum Rights 18:9
Mehta, Sanjay R; Chaillon, Antoine; Gaines, Tommi L et al. (2018) Impact of Public Safety Policies on Human Immunodeficiency Virus Transmission Dynamics in Tijuana, Mexico. Clin Infect Dis 66:758-764
Dinesha, T R; Boobalan, J; Sivamalar, S et al. (2018) Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV. J Viral Hepat 25:718-723
Fraser, Hannah; Zibbell, Jon; Hoerger, Thomas et al. (2018) Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction 113:173-182

Showing the most recent 10 out of 921 publications